Managing Vaginal GVHD Webinar

Graft-versus-host disease (GVHD) can affect many organs and tissues after transplant, including the vagina. Learn who's at risk of developing vaginal GVHD and how to treat it.

Printer-friendly version Tuesday, September 27, 2022

Are you living with vaginal graft-versus-host disease?  

If so, this is a webinar you won't want to miss!

Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the vagina..

Up to 50% of women develop vaginal GVHD after transplant. It occurs most often in patients who have GVHD in another part of their body, typically the skin or mouth.

Vaginal GVHD can cause lesions, scarring, pain with intercourse and, in some cases, narrowing of the vaginal canal.

Learn more about this important topic in this free one-hour webinar from BMT InfoNet:

Managing Vaginal GVHD

Tuesday, September 27, 2022

7 pm Eastern, 6 pm Central,  5 pm Mountain,  4 pm Pacific

Gynecologist and GVHD expert, Dr. Lenira Maria Queiroz Mauad will explain:

  • who's at risk of developing vaginal GVHD
  • symptoms of vaginal GVHD
  • how to examine yourself for symptoms of GVHD
  • how to manage the pain and get prompt treatment



The webinar is free, but advance registration is required.  All you will need to participate is a computer, smartphone, or another electronic device.

"Dr. Mauad is a world authority on genitourinary GVHD and sexual health post- transplant. She is a wonderful speaker and I always learn so much from her lectures.  Her mission is rooted in restoring quality of life to women undergoing cancer therapy and allogeneic transplantation.  She is one of a kind!!"  Amin Alousi MD, Director of the GVHD Clinic and Research Program at MD Anderson Cancer Center

About the Speakers 

Dr. Lenira Maria Queiroz Mauad is a gynecologist who has worked with stem cell transplant patients at the Amaral Carvalho Hospital in the state of  São Paulo, Brazil since 2008.  An expert in genital GVHD, she has helped develop guidelines for the treatment of vaginal GVHD for the Brazilian Society of Cell Therapy and Bone Marrow Transplantation

Joining Dr. Mauad will be Vaneuza Araújo Moreira Funke, MD, MS

Dr. Vaneuza Araújo Moreira Funke is the head of the adult stem cell transplant program at the Universidade Federal do Paraná in Curitiba, Brazil, and chair of the  hematology/oncology division. Her research interests include graft-versus-host disease (GVHD), acute leukemia, chronic myeloid leukemia, myeloproliferative disorders and long-term follow-up after stem cell transplants. She is a member of the Brazilian Society of HSCT (hematopoietic stem cell transplantation) and the American Society for Transplant and Cellular therapy.

Many thanks to Kadmon, a Sanofi company and Syndax Pharmaceuticals whose support, in part, made this webinar possible.